INFLAMMATORY MYOPATHY
Clinical trials for INFLAMMATORY MYOPATHY explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY MYOPATHY trials appear
Sign up with your email to follow new studies for INFLAMMATORY MYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-phase study tests a new cell treatment called YTS109 in 18 adults with severe autoimmune diseases like lupus and vasculitis that have not responded to standard therapies. Participants receive a single infusion of these specially engineered cells. The main goal is to ch…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
New cell therapy trial aims to tame tough autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new cell treatment called YTS109 in 18 adults with hard-to-treat autoimmune diseases like lupus and Sjogren's syndrome. The main goal is to check if the treatment is safe, and also to see if it helps control the disease. Participants receive a singl…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Universal CAR T-Cells aim to tame autoimmune attacks in early trial
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR T-cells) that target two proteins, CD19 and BCMA, found on faulty immune cells. The goal is to see if it is safe and can help control severe autoimmune diseases like lupus and scleroderma that have not …
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New cell shot aims to tame Out-of-Control immune attacks
Disease control Recruiting nowThis early study tests a new cell treatment called YTS109 in 18 adults with severe autoimmune diseases like lupus and scleroderma that haven't improved with standard care. Participants get a single infusion of these specially designed cells. The main goal is to see if the treatme…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Revolutionary In-Body CAR-T therapy targets autoimmune diseases
Disease control Recruiting nowThis early-phase study tests a new treatment called TI-0032-III for people with severe autoimmune diseases like lupus and Sjögren's syndrome that haven't improved with standard care. The treatment uses a special injection to create CAR-T cells inside the body, which then target a…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New cell therapy aims to tame tough autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new cell treatment called YTS109 in about 18 adults with autoimmune diseases like lupus that have not responded to standard therapies. Participants receive a single infusion of these specially designed cells. The main goal is to check safety and see…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Patients take the lead: rare disease research gets a new voice
Knowledge-focused Recruiting nowThis study asks people living with rare myositis diseases (and their caregivers) what research questions matter most to them. Researchers will collect ideas through online surveys and forums. The goal is to create a patient-driven list of priorities to guide future studies and fu…
Matched conditions: INFLAMMATORY MYOPATHY
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC